Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Orange source : Nutriband.com save search
Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology
Published: 2023-06-23 (Crawled : 11:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: 4.59%
H: 1.54%
C: -11.92%
patent transdermal technology
Nutriband to Attend 2023 BIO International Convention
Published: 2023-05-10 (Crawled : 12:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: -6.34%
H: 0.0%
C: -6.47%
international
Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023
Published: 2023-04-27 (Crawled : 12:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: -2.77%
H: 3.77%
C: -0.57%
Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023
Published: 2023-04-19 (Crawled : 11:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: -8.55%
H: 15.66%
C: 15.66%
microcap
Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development
Published: 2023-04-04 (Crawled : 11:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: 1.97%
H: 4.84%
C: 1.61%
drug commercial
Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology
Published: 2023-03-28 (Crawled : 12:00) - nutriband.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -1.33%
H: 0.0%
C: 0.0%
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: 0.0%
H: 2.0%
C: 0.0%
transdermal commercialization technology
Nutriband Inc Joins Webull Corporate Communications Service Platform
Published: 2023-03-08 (Crawled : 13:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: -0.13%
H: 1.88%
C: -0.72%
service communications platform
Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee
Published: 2023-03-02 (Crawled : 13:00) - nutriband.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 1.68%
H: 0.0%
C: 0.0%
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: 0.0%
H: 3.33%
C: 0.0%
fda research
Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador’s Health Register
Published: 2023-02-15 (Crawled : 11:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: 10.89%
H: 4.91%
C: -6.7%
america health distribution
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
Published: 2023-01-24 (Crawled : 11:00) - nutriband.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.27%
H: 0.1%
C: 0.1%
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: -2.85%
H: 0.0%
C: -1.76%
RANI | $6.86 13.39% 11.81% 200K
|
|
| O: -1.1%
H: 1.91%
C: -3.82%
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 0.11%
H: 0.0%
C: -1.35%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: -0.86%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
conference transdermal
Nutriband Inc. Commences Trading on Upstream Under NTRB
Published: 2023-01-05 (Crawled : 11:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: 0.0%
H: 3.93%
C: 1.54%
Nutriband Inc. Will Be the First Company to Dual List on Upstream
Published: 2022-12-30 (Crawled : 11:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: 1.63%
H: 0.0%
C: -3.87%
Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023
Published: 2022-12-29 (Crawled : 12:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: 1.09%
H: 1.35%
C: -0.54%
Nutriband Approved for Dual Listing on Upstream
Published: 2022-12-14 (Crawled : 12:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: -2.92%
H: 4.37%
C: 4.37%
approved
Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3
Published: 2022-12-05 (Crawled : 12:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: -3.79%
H: 3.67%
C: 0.26%
Nutriband Inc to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
Published: 2022-12-02 (Crawled : 13:20) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: -0.26%
H: 2.31%
C: 1.8%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -1.63%
H: 6.61%
C: 4.13%
conference growth
Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA™ Abuse Deterrent Transdermal Technology Patent
Published: 2022-12-01 (Crawled : 12:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: -1.02%
H: 5.93%
C: 0.52%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -0.77%
H: 2.33%
C: -4.65%
patent transdermal technology
Nutriband Supports Newly Published CDC Opioid Prescribing Guidelines
Published: 2022-11-08 (Crawled : 12:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: -6.56%
H: 6.78%
C: -0.73%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 1.38%
H: 2.72%
C: 0.0%
guidelines opioid
Nutriband Inc. to Manufacture Fleur Marché-branded Wellness Patches Under Exclusive Agreement
Published: 2022-10-27 (Crawled : 11:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: 8.17%
H: 0.0%
C: -1.33%
JWN | $18.92 0.96% 0.0% 4M
|
Retail Trade
|
| O: 1.25%
H: 1.66%
C: -2.27%
URBN | $36.96 -0.16% -0.16% 1.5M
|
Retail Trade
|
| O: 0.94%
H: 1.54%
C: -0.2%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 1.26%
H: 0.62%
C: -4.97%
BBBY | $0.0751 -27.09% -47.14% 190M
|
Retail Trade
|
| O: 5.95%
H: 5.14%
C: -3.49%
agreement
Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheumatology Conference
Published: 2022-10-26 (Crawled : 12:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K
|
Manufacturing
|
| O: 0.24%
H: 10.71%
C: -0.95%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -3.14%
H: 10.39%
C: 3.25%
conference therapeutics study phase 2b
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.